Pembrolizumab-induced focal segmental glomerulosclerosis: A case report

RATIONALE: Focal segmental glomerulosclerosis (FSGS) is the most common primary glomerular disorder that leads to end-stage kidney disease. Pembrolizumab, an immune checkpoint inhibitor, is an anti-programmed death 1 (PD-1) immunoglobulin G4 antibody approved for the treatment of advanced melanoma a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Da Woon, Jeon, Hakeong, Kim, Sungmi, Lee, Wanhee, Kim, Hyo Jin, Rhee, Harin, Song, Sang Heon, Seong, Eun Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556051/
https://www.ncbi.nlm.nih.gov/pubmed/34713828
http://dx.doi.org/10.1097/MD.0000000000027546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556051/
https://www.ncbi.nlm.nih.gov/pubmed/34713828
http://dx.doi.org/10.1097/MD.0000000000027546

Ejemplares similares